Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Nitric oxide releasing derivatives of paracetamol patented

April 14, 2009

KAI initiates third phase IIa KAI-1678 trial for neuropathic pain

April 9, 2009

IntelGenx and Cary file NDA for antidepressant, CPI-300

April 9, 2009

Amarin's MAA for AMR-101 in Huntington's disease accepted for review

April 9, 2009

Somaxon provides update on NDA for Silenor for insomnia

April 9, 2009

Avineuro commences phase I AVN-101 study for Alzheimer's disease

April 9, 2009

Novel inhibitors of Abeta calcium channel activity confer neuroprotection in vitro

April 9, 2009

Schering-Plough patent discloses novel gamma-secretase modulators for the treatment of AD

April 9, 2009

FDA Advisory Committee provides opinion on Serdolect in schizophrenia

April 8, 2009

Aplenzin extended-release tablets available in the U.S.

April 8, 2009

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...